Stem cell therapy offers a regenerative and effective solution for pain, limited mobility, and reduced quality of life caused by cartilage disorders. Mesenchymal stem cells repair damaged cartilage tissue, strengthen joint function, reduce inflammation, and provide long-term healing.
Cartilage tissue is an essential structure for the healthy movement of our joints. Thanks to its shock-absorbing capacity, protective surface, and smooth texture that reduces friction, it allows stable and pain-free mobility throughout life. However, because cartilage does not contain blood vessels, its ability to regenerate is extremely limited. Therefore, trauma, aging, overuse, sports injuries, or degenerative diseases can gradually lead to cartilage damage and a reduction in mobility. Stemcell Consultancy aims to strengthen joint function and improve quality of life through stem cell therapy, offering regenerative medicine–based solutions for cartilage disorders.
Although the natural structure of cartilage helps maintain its durability, various factors may weaken or damage this tissue over time. The most common causes include:
• Aging and reduced joint fluid
• Osteoarthritis (degenerative joint disease)
• Sports injuries
• Trauma and impact
• Excessive joint load due to obesity
• Repetitive movements
• Genetic factors
• Intra-articular inflammation
When cartilage deteriorates, friction between the joints increases, leading to pain, stiffness, and loss of mobility. While traditional treatments mainly focus on managing symptoms, stem cell therapy aims to directly regenerate damaged cartilage tissue.
Compared to other tissues in the body, cartilage has a very limited healing capacity. The main reasons for this include:
• Lack of blood vessels: Without blood flow, nutrient-carrying cells cannot reach the tissue quickly to repair it.
• Slow cell cycle: Chondrocytes (cartilage cells) have a low replication capacity.
• Ongoing mechanical load: As joints continue to move constantly, cartilage loss accelerates.
Stem cell therapy enhances this limited regenerative capacity and triggers the natural healing process.
The effectiveness of mesenchymal stem cells (MSCs) in cartilage repair has been demonstrated in numerous scientific studies. MSCs support cartilage regeneration through the following mechanisms:
1. Increasing Chondrocyte Formation: Stem cells can differentiate into cartilage cells and help restore missing tissue.
2. Reducing Inflammation: Inflammation plays a major role in cartilage disorders. MSCs exhibit strong anti-inflammatory effects.
3. Improving Synovial Fluid Quality: They help rebalance the joint’s natural lubrication system.
4. Tissue Repair: They support the healing of connective tissue, tendons, and joint capsule structures.
5. Reduced Pain and Stiffness: Cellular changes support improved joint function.
At Stemcell Consultancy, stem cell therapy can be an effective option for conditions such as:
• Osteoarthritis
• Knee cartilage damage
• Meniscus injuries
• Hip cartilage disorders
• Shoulder cartilage problems
• Osteochondritis dissecans
• Ankle cartilage injuries
• Sports-related injuries
• Early-stage cartilage degeneration
The stem cells used in our cartilage treatments are young and highly viable umbilical cord–derived mesenchymal stem cells. These cells have strong regenerative potential and are prepared under GMP standards.
The treatment protocol may include:
• Targeted intra-cartilage stem cell injections
• MSC support around the joint
• Exosome and growth factor therapies
• Systemic IV administration
• PRP (Platelet-Rich Plasma) when needed
Clinical research shows that stem cell therapy provides the following benefits for cartilage health:
• Strengthens cartilage integrity
• Reduces pain and inflammation
• Improves mobility
• Supports joint spacing
• May reduce the need for surgery
• Provides long-term healing
• Has a high safety profile
• Offers faster return to activity for athletes
The treatment process follows a comprehensive protocol implemented by Stemcell Consultancy.
The patient’s MRI, X-ray, and physical examination findings are reviewed. The degree of cartilage loss, joint structure, and inflammation level are analyzed.
Injection sites, stem cell dosage, and additional therapies are determined based on the level of cartilage damage.
The stem cells to be used undergo preparation in GMP laboratories. This process includes viability, sterility, and quality assessments.
The procedure is usually performed under local anesthesia. Stem cells are injected into or around the targeted joint. In some cases, IV administration is used as additional support.
Follow-up appointments are scheduled after treatment, and improvements in joint function are monitored.
Clinical data show that stem cell therapy provides promising results for many patients with cartilage disorders:
• Significant reduction in pain
• Improvement in joint structure
• Increased cartilage thickness in MRI images
• Better performance in daily activities
• Increased exercise capacity
Success rates are particularly high in early- and mid-stage cartilage damage.
• Individuals with joint pain
• Athletes with cartilage injuries
• People in early or moderate stages of osteoarthritis
• Those seeking non-surgical alternatives
• Individuals wanting to preserve joint cartilage health
• Advanced cases with completely lost cartilage
• Uncontrolled rheumatic diseases
• Active infection
• Severe joint deformities
Umbilical cord–derived MSCs have a high safety profile. Side effects are minimal and usually limited to mild sensitivity at the injection site.
• Regular weekly exercise
• Weight management
• Strengthening surrounding muscles
• Anti-inflammatory nutrition
• Joint-friendly lifestyle habits
• Regular physical therapy
Cartilage disorders significantly reduce quality of life. The stem cell–based treatments offered by Stemcell Consultancy aim to provide patients with a healthier, more active lifestyle by naturally supporting joint function.
You can create your personalized treatment plan with Stemcell Consultancy for greater flexibility, less pain, and stronger joint mobility.